| Literature DB >> 31581313 |
Ana-Marija Vučković1, Valentina Bosello Travain1, Luciana Bordin1, Giorgio Cozza1, Giovanni Miotto1, Monica Rossetto1, Stefano Toppo1, Rina Venerando1, Mattia Zaccarin1, Matilde Maiorino1, Fulvio Ursini1, Antonella Roveri1.
Abstract
Ras-selective lethal small molecule 3 (RSL3), a drug candidate prototype for cancer chemotherapy, triggers ferroptosis by inactivating the glutathione peroxidase glutathione peroxidase 4 (GPx4). Here, we report the purification of the protein indispensable for GPx4 inactivation by RSL3. Mass spectrometric analysis identified 14-3-3 isoforms as candidates, and recombinant human 14-3-3ε confirms the identification. The function of 14-3-3ε is redox-regulated. Moreover, overexpression or silencing of the gene coding for 14-3-3ε consistently controls the inactivation of GPx4 by RSL3. The interaction of GPx4 with a redox-regulated adaptor protein operating in cell signaling further contributes to frame it within redox-regulated pathways of cell survival and death and opens new therapeutic perspectives.Entities:
Keywords: 14-3-3 proteins; RSL3; ferroptosis; glutathione peroxidase 4; protein; protein interaction; redox regulation
Year: 2019 PMID: 31581313 DOI: 10.1002/1873-3468.13631
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124